On the public citation graph

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis

https://doi.org/10.1056/nejmoa1810742
0 signed · 532 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ejhf.823openalex-snapshot
Effects of Ferric Carboxymaltose on Hospitalisations and Mortality Rates in Iron-Deficient Heart Failure Patients: An Individual Patient data Meta-Analysis
inferredcites →https://doi.org/10.1016/j.chom.2013.04.010openalex-snapshot
Iron in Infection and Immunity
inferredcites →https://doi.org/10.1016/j.cjca.2015.06.009openalex-snapshot
The Efficacy and Safety of Iron Supplementation in Patients With Heart Failure and Iron Deficiency: A Systematic Review and Meta-analysis
inferredcites →https://doi.org/10.1016/j.ejim.2018.04.013openalex-snapshot
Iron deficiency in chronic and acute heart failure: A contemporary review on intertwined conditions
inferredcites →https://doi.org/10.1016/j.ihj.2017.10.009openalex-snapshot
Effect of ferric carboxymaltose on hospitalization and mortality outcomes in chronic heart failure: A meta-analysis
inferredcites →https://doi.org/10.1016/j.kint.2015.10.002openalex-snapshot
Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
inferredcites →https://doi.org/10.1038/ki.2012.76openalex-snapshot
The health-related quality of life was not improved by targeting higher hemoglobin in the Normal Hematocrit Trial
inferredcites →https://doi.org/10.1038/ki.2014.275openalex-snapshot
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
inferredcites →https://doi.org/10.1038/kisup.2012.37openalex-snapshot
Notice
inferredcites →https://doi.org/10.1038/srep16670openalex-snapshot
Oral iron acutely elevates bacterial growth in human serum
inferredcites →https://doi.org/10.1056/nejm199808273390903openalex-snapshot
The Effects of Normal as Compared with Low Hematocrit Values in Patients with Cardiac Disease Who Are Receiving Hemodialysis and Epoetin
inferredcites →https://doi.org/10.1056/nejmoa062276openalex-snapshot
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
inferredcites →https://doi.org/10.1056/nejmoa065485openalex-snapshot
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
inferredcites →https://doi.org/10.1056/nejmoa0907845openalex-snapshot
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
inferredcites →https://doi.org/10.1080/08860220802599106openalex-snapshot
Lipid Peroxidation Products Formation with Various Intravenous Iron Preparations in Chronic Kidney Disease
inferredcites →https://doi.org/10.1093/ckj/sfv142openalex-snapshot
Safety concerns about intravenous iron therapy in patients with chronic kidney disease
inferredcites →https://doi.org/10.1093/ndt/gfq858openalex-snapshot
Iron and vascular calcification. Is there a link?
inferredcites →https://doi.org/10.1093/ndt/gft062openalex-snapshot
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)
inferredcites →https://doi.org/10.1111/1467-9868.00259openalex-snapshot
Semiparametric Regression for the Mean and Rate Functions of Recurrent Events
inferredcites →https://doi.org/10.1111/j.0006-341x.2000.00554.xopenalex-snapshot
Nonparametric Analysis of Recurrent Events and Death
inferredcites →https://doi.org/10.1126/science.1224577openalex-snapshot
Hepcidin and the Iron-Infection Axis
inferredcites →https://doi.org/10.1128/iai.00253-18openalex-snapshot
Hepcidin Protects against Lethal Escherichia coli Sepsis in Mice Inoculated with Isolates from Septic Patients
inferredcites →https://doi.org/10.1136/bmj.296.6634.1454openalex-snapshot
Statistics in Medicine: Calculating confidence intervals for some non-parametric analyses
inferredcites →https://doi.org/10.1159/000486968openalex-snapshot
Positive Iron Balance in Chronic Kidney Disease: How Much is Too Much and How to Tell?
inferredcites →https://doi.org/10.1159/000493551openalex-snapshot
Randomized Trial Comparing Proactive, High-Dose versus Reactive, Low-Dose Intravenous Iron Supplementation in Hemodialysis (PIVOTAL): Study Design and Baseline Data
inferredcites →https://doi.org/10.1371/journal.pone.0078930openalex-snapshot
Intravenous Iron Supplementation Practices and Short-Term Risk of Cardiovascular Events in Hemodialysis Patients
inferredcites →https://doi.org/10.1681/asn.2005040423openalex-snapshot
Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients
inferredcites →https://doi.org/10.1681/asn.2012121164openalex-snapshot
Infection Risk with Bolus versus Maintenance Iron Supplementation in Hemodialysis Patients
inferredcites →https://doi.org/10.2215/cjn.03370414openalex-snapshot
Intravenous Iron Exposure and Mortality in Patients on Hemodialysis
inferredcites →https://doi.org/10.2215/cjn.05390517openalex-snapshot
Safety of Intravenous Iron in Dialysis
inferredcites →https://doi.org/10.3109/08037059209077502openalex-snapshot
Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials
inferredcites →https://doi.org/10.3389/fcimb.2017.00110openalex-snapshot
Genetic and Dietary Iron Overload Differentially Affect the Course of Salmonella Typhimurium Infection

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4134306openalex-extracted
inferred← citeshttps://doi.org/10.1001/jama.2024.16338openalex-snapshot
Dialysis for Chronic Kidney Failure
inferred← citeshttps://doi.org/10.1001/jamainternmed.2021.5726openalex-snapshot
Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.33935openalex-snapshot
Risk of Infection Associated With Administration of Intravenous Iron
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.34453openalex-snapshot
Intravenous Iron and Infection Risk—Still an Unanswered Question
inferred← citeshttps://doi.org/10.1002/9781394210916.ch10openalex-snapshot
Iron Deficiency in Renal Medicine
inferred← citeshttps://doi.org/10.1002/ajh.26427openalex-snapshot
The iron revolution: Keeping abreast of the developments in iron therapy
inferred← citeshttps://doi.org/10.1002/ajh.26819openalex-snapshot
The clinical relevance of detectable plasma iron species in iron overload states and subsequent to intravenous iron‐carbohydrate administration
inferred← citeshttps://doi.org/10.1002/ajh.27220openalex-snapshot
Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions
inferred← citeshttps://doi.org/10.1002/ajh.70329openalex-snapshot
Mind the Gap: Underdosing of Intravenous Iron in a Hospitalized Patient Population With Iron‐Deficiency Anemia
inferred← citeshttps://doi.org/10.1002/ejhf.1531openalex-snapshot
Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology
inferred← citeshttps://doi.org/10.1002/ejhf.2816openalex-snapshot
Dosing of Iron Supplementation for Iron-Deficient Patients with Heart Failure: Should we Prefer More Intensive or Less Intensive Repletion Targets?
inferred← citeshttps://doi.org/10.1002/ejhf.3024openalex-snapshot
2023 Focused Update of the 2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
inferred← citeshttps://doi.org/10.1002/ejhf.3237openalex-snapshot
Critical Re-Evaluation of the Identification of Iron Deficiency States and Effective Iron Repletion Strategies in Patients with Chronic Heart Failure
inferred← citeshttps://doi.org/10.1002/ejhf.3504openalex-snapshot
Effect of Correcting Iron Deficiency on the Risk of Serious Infection in Heart Failure: Insights from the IRONMAN Trial
inferred← citeshttps://doi.org/10.1002/ejhf.3589openalex-snapshot
What’s New in Heart Failure? January 2025
inferred← citeshttps://doi.org/10.1002/ejhf.3670openalex-snapshot
Recurrent Event Analyses in Patients Receiving Maintenance Dialysis and the Effect of Higher- Versus Lower-Dose Chronic Intravenous Iron Therapy: A Report Focusing on Heart Failure Events from the PIVOTAL Trial
inferred← citeshttps://doi.org/10.1002/ejhf.3737openalex-snapshot
What's New in Heart Failure? June 2025
inferred← citeshttps://doi.org/10.1002/fsn3.3731openalex-snapshot
A low‐fat synbiotic cream cheese containing herbal gums, Bifidobacterium adolescentis and Lactobacillus rhamnosus: Physicochemical, rheological, sensory, and microstructural characterization during storage
inferred← citeshttps://doi.org/10.1002/jac5.1675openalex-snapshot
Assessing impact of an interdisciplinary erythropoiesis‐stimulating agent dosing protocol at an outpatient community hospital hemodialysis unit
inferred← citeshttps://doi.org/10.1002/jcph.1997openalex-snapshot
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate
inferred← citeshttps://doi.org/10.1002/jhm.13027openalex-snapshot
Clinical progress note: Inpatient management of iron deficiency anemia
inferred← citeshttps://doi.org/10.1002/prp2.628openalex-snapshot
A pharmacist‐managed dosing algorithm for darbepoetin alfa and iron sucrose in hemodialysis patients: A randomized, controlled trial
inferred← citeshttps://doi.org/10.1002/smll.202507309openalex-snapshot
Tumor Microenvironment‐Triggered Intelligent Nanoassemblies for Fluorescence Imaging Activation and Tumor‐Specific Embolization Therapy Amplification
inferred← citeshttps://doi.org/10.1007/978-3-030-56890-0_51openalex-snapshot
Nephrology in the United Kingdom
inferred← citeshttps://doi.org/10.1007/978-3-030-62087-5_45openalex-snapshot
Management of Anemia in Peritoneal Dialysis Patients
inferred← citeshttps://doi.org/10.1007/978-3-030-70897-9_18openalex-snapshot
Anemia Management in Peritoneal Dialysis
inferred← citeshttps://doi.org/10.1007/978-3-030-83082-3_13openalex-snapshot
Anemia in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-98824-1_14openalex-snapshot
Chronic Kidney Disease Is a Risk Enhancer for Cardiovascular Diseases
inferred← citeshttps://doi.org/10.1007/978-3-031-09131-5_7openalex-snapshot
Management of Anaemia in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-11665-0_58openalex-snapshot
Nutritional Challenges in Pediatric Kidney Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-42045-0_15openalex-snapshot
Anemia and Disorders of Hemostasis in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-77244-3_18openalex-snapshot
Anemia Management in Home Hemodialysis
inferred← citeshttps://doi.org/10.1007/978-3-032-12399-2_6openalex-snapshot
Nephrology
inferred← citeshttps://doi.org/10.1007/978-3-319-90760-4_45-1openalex-snapshot
Management of Anemia in Peritoneal Dialysis Patients
inferred← citeshttps://doi.org/10.1007/978-981-92-1167-8_5openalex-snapshot
Management of Anemia of Renal Failure
inferred← citeshttps://doi.org/10.1007/s00108-021-01170-2openalex-snapshot
Niereninsuffizienz im Kontext der kardiopulmorenalen Pathophysiologie
inferred← citeshttps://doi.org/10.1007/s00223-020-00804-1openalex-snapshot
Iron Sucrose: A Double-Edged Sword in High Phosphate Media-Induced Vascular Calcification
inferred← citeshttps://doi.org/10.1007/s00467-021-05191-9openalex-snapshot
Erythropoiesis-independent effects of iron in chronic kidney disease
inferred← citeshttps://doi.org/10.1007/s10157-026-02862-5openalex-snapshot
Relationship between iron deficiency and corrected QT-interval prolongation in Japanese patients undergoing maintenance hemodialysis
inferred← citeshttps://doi.org/10.1007/s10620-022-07599-1openalex-snapshot
Ironing It All Out: A Comprehensive Review of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients
inferred← citeshttps://doi.org/10.1007/s10741-023-10318-1openalex-snapshot
Implications of uremic cardiomyopathy for the practicing clinician: an educational review
inferred← citeshttps://doi.org/10.1007/s10741-024-10415-9openalex-snapshot
Management of patients with heart failure and chronic kidney disease
inferred← citeshttps://doi.org/10.1007/s10741-024-10453-3openalex-snapshot
Heart failure with reduced ejection fraction and chronic kidney disease: a focus on therapies and interventions
inferred← citeshttps://doi.org/10.1007/s11096-023-01548-2openalex-snapshot
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
inferred← citeshttps://doi.org/10.1007/s11255-019-02273-4openalex-snapshot
Infectious complications and mortality associated with the use of IV iron therapy: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s11255-021-02952-1openalex-snapshot
Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients
inferred← citeshttps://doi.org/10.1007/s11255-021-02983-8openalex-snapshot
Preliminary experience on the use of sucrosomial iron in hemodialysis: focus on safety, hemoglobin maintenance and oxidative stress
inferred← citeshttps://doi.org/10.1007/s11255-023-03549-6openalex-snapshot
Trends in mortality and comorbidities in hemodialysis patients between 2012 and 2017 in an East-European Country: a retrospective study
inferred← citeshttps://doi.org/10.1007/s11255-023-03741-8openalex-snapshot
Cardiorenal syndrome and iron supplementation—more benefits than risks: a narrative review
inferred← citeshttps://doi.org/10.1007/s11255-024-04146-xopenalex-snapshot
Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis
inferred← citeshttps://doi.org/10.1007/s11560-023-00635-9openalex-snapshot
Prolylhydroxylaseinhibitoren – „new kids in the blood“
inferred← citeshttps://doi.org/10.1007/s11906-024-01314-3openalex-snapshot
Is There a Role for SGLT2 Inhibitors in Patients with End-Stage Kidney Disease?
inferred← citeshttps://doi.org/10.1007/s12325-019-01089-zopenalex-snapshot
Economic Evaluation of Ferric Carboxymaltose for the Management of Hemodialysis Patients with Iron Deficiency Anemia in Italy
inferred← citeshttps://doi.org/10.1007/s12325-020-01323-zopenalex-snapshot
Iron Sucrose: A Wealth of Experience in Treating Iron Deficiency
inferred← citeshttps://doi.org/10.1007/s12325-021-01826-3openalex-snapshot
The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients
inferred← citeshttps://doi.org/10.1007/s12325-023-02727-3openalex-snapshot
Risk Factors for Thromboembolic Events in Patients With Dialysis-Dependent CKD: Pooled Analysis of Phase 3 Roxadustat Trials in Japan
inferred← citeshttps://doi.org/10.1007/s12325-024-03015-4openalex-snapshot
Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Dialysis-Dependent Patients with Anaemia of Chronic Kidney Disease: A Retrospective Observational Study
inferred← citeshttps://doi.org/10.1007/s12325-025-03366-6openalex-snapshot
Podcast Synopsis of Updates to the European Renal Best Practice and UK Kidney Association Guidelines for Treatment of Anaemia in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1007/s15006-025-5435-0openalex-snapshot
Eisenmangel bei Herzinsuffizienz
inferred← citeshttps://doi.org/10.1007/s40265-022-01783-3openalex-snapshot
Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors
inferred← citeshttps://doi.org/10.1007/s40620-020-00908-9openalex-snapshot
Calciphylaxis in end-stage kidney disease: outcome data from the United Kingdom Calciphylaxis Study
inferred← citeshttps://doi.org/10.1007/s40620-023-01571-6openalex-snapshot
Predictors of quality of life in patients within the first year of commencing haemodialysis based on baseline data from the PIVOTAL trial and associations with the study outcomes
inferred← citeshttps://doi.org/10.1007/s40620-024-02117-0openalex-snapshot
Ziltivekimab for anemia and atherosclerosis in chronic kidney disease: a new hope?
inferred← citeshttps://doi.org/10.1007/s40620-025-02363-wopenalex-snapshot
Longitudinal associations between iron status and patient-reported outcomes in incident dialysis patients: a DOMESTICO substudy
inferred← citeshttps://doi.org/10.1007/s40620-025-02422-2openalex-snapshot
A European Delphi study on the management of anaemia of CKD: unmet needs in personalized treatment
inferred← citeshttps://doi.org/10.1007/s40801-024-00418-1openalex-snapshot
Effect of Ferric Carboxymaltose Versus Low-Dose Intravenous Iron Therapy and Iron Sucrose on the Total Cost of Care in Patients with Iron Deficiency Anemia: A US Claims Database Analysis
inferred← citeshttps://doi.org/10.1016/b978-0-12-815876-0.00032-2openalex-snapshot
Immune Function in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-818540-7.00035-5openalex-snapshot
Nutrition and anemia in chronic kidney disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-79135-9.00037-9openalex-snapshot
Anemia and Its Treatment in Patients With End-Stage Kidney Disease
inferred← citeshttps://doi.org/10.1016/b978-0-323-79135-9.00038-0openalex-snapshot
Resistance to Erythropoiesis Stimulating Agent (ESA) Treatment
inferred← citeshttps://doi.org/10.1016/b978-0-323-79135-9.00084-7openalex-snapshot
Management of Anemia in Children Undergoing Dialysis
inferred← citeshttps://doi.org/10.1016/b978-0-323-87862-3.00025-2openalex-snapshot
Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients With Type 2 Diabetes
inferred← citeshttps://doi.org/10.1016/b978-3-437-23841-3.00041-2openalex-snapshot
Literatur
inferred← citeshttps://doi.org/10.1016/j.amjcard.2023.12.006openalex-snapshot
Spontaneous Improvement in Iron Parameters and the Relation With Changes in Functionality in Heart Failure
inferred← citeshttps://doi.org/10.1016/j.blre.2024.101227openalex-snapshot
Absolute and functional iron deficiency: Biomarkers, impact on immune system, and therapy
inferred← citeshttps://doi.org/10.1016/j.ccl.2021.04.003openalex-snapshot
Anemia: A Connection Between Heart Failure and Kidney Failure
inferred← citeshttps://doi.org/10.1016/j.ccl.2021.04.011openalex-snapshot
Atherosclerotic Vascular Disease Associated with Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1016/j.diabet.2025.101626openalex-snapshot
Increased ferritin levels are associated with incident diabetes after kidney transplantation: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.ebiom.2019.01.005openalex-snapshot
Treatment of anaemia in end-stage renal disease: A double-edged iron sword?
inferred← citeshttps://doi.org/10.1016/j.ebiom.2022.103921openalex-snapshot
Post-mortem liver and bone marrow iron quantification in haemodialysis patients: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.ebiom.2023.104929openalex-snapshot
Relationship between bone marrow iron load and liver iron concentration in dialysis-associated haemosiderosis
inferred← citeshttps://doi.org/10.1016/j.ejim.2025.106506openalex-snapshot
Anemia in cardiorenal disease: From pathogenesis to treatment
inferred← citeshttps://doi.org/10.1016/j.ejim.2025.106614openalex-snapshot
The challenges of anemia management in cardiorenal disease
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.02.023openalex-snapshot
SAT-019 INCIDENCE, RISK FACTORS, AETIOLOGIES AND OUTCOME OF ACUTE KIDNEY INJURY AMONG PAEDIATRIC ADMISSIONS IN A REFERRAL HOSPITAL IN CAMEROON
inferred← citeshttps://doi.org/10.1016/j.ekir.2020.10.035openalex-snapshot
Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.05.020openalex-snapshot
Treatment of Iron Deficiency Anemia in CKD and End-Stage Kidney Disease
inferred← citeshttps://doi.org/10.1016/j.ekir.2021.07.032openalex-snapshot
Iron Deficiency in CKD Without Concomitant Anemia
inferred← citeshttps://doi.org/10.1016/j.ekir.2022.05.008openalex-snapshot
An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.06.004openalex-snapshot
Infectious Risk and Variability of Hemoglobin Level in Patients Undergoing Hemodialysis
inferred← citeshttps://doi.org/10.1016/j.ekir.2023.09.009openalex-snapshot
Contemporary Practice of Anemia Treatment Among Dialysis Patients in the United States
inferred← citeshttps://doi.org/10.1016/j.ekir.2024.01.015openalex-snapshot
Anemia in Pregnancy With CKD
inferred← citeshttps://doi.org/10.1016/j.ekir.2025.01.029openalex-snapshot
Systematic Review of the Effects of Iron on Cardiovascular, Kidney, and Safety Outcomes in Patients With CKD
inferred← citeshttps://doi.org/10.1016/j.freeradbiomed.2020.01.024openalex-snapshot
The pathogenesis of CKD complications; Attack of dysregulated iron and phosphate metabolism
inferred← citeshttps://doi.org/10.1016/j.heliyon.2019.e02045openalex-snapshot
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations
inferred← citeshttps://doi.org/10.1016/j.ijcha.2022.101038openalex-snapshot
Short-term treatment of iron deficiency anemia after cardiac surgery
inferred← citeshttps://doi.org/10.1016/j.jacc.2021.11.039openalex-snapshot
Criteria for Iron Deficiency in Patients With Heart Failure
inferred← citeshttps://doi.org/10.1016/j.jacc.2024.08.052openalex-snapshot
Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure
inferred← citeshttps://doi.org/10.1016/j.jacc.2026.01.089openalex-snapshot
Cardiovascular Trials in Hemodialysis
inferred← citeshttps://doi.org/10.1016/j.jchf.2021.04.005openalex-snapshot
Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy
inferred← citeshttps://doi.org/10.1016/j.jclinepi.2020.12.003openalex-snapshot
Estimating and testing an index of bias attributable to composite outcomes in comparative studies
inferred← citeshttps://doi.org/10.1016/j.jval.2025.03.019openalex-snapshot
Mapping the Kidney Disease Quality-of-Life Questionnaire Onto the EQ-5D-5L Utility Index in Patients Undergoing Hemodialysis
inferred← citeshttps://doi.org/10.1016/j.kint.2019.01.003openalex-snapshot
Iron and oxygen sensing: discovering intricate links
inferred← citeshttps://doi.org/10.1016/j.kint.2019.01.013openalex-snapshot
High-dose IV iron for anemia correction in chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.kint.2021.03.020openalex-snapshot
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
inferred← citeshttps://doi.org/10.1016/j.kint.2021.07.013openalex-snapshot
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.kint.2023.05.009openalex-snapshot
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
inferred← citeshttps://doi.org/10.1016/j.kint.2024.07.030openalex-snapshot
Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients
inferred← citeshttps://doi.org/10.1016/j.kint.2025.06.005openalex-snapshot
Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
inferred← citeshttps://doi.org/10.1016/j.kint.2025.06.006openalex-snapshot
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
inferred← citeshttps://doi.org/10.1016/j.kint.2026.09.007openalex-snapshot
Recommendations for the Management of Anemia in Patients with Cancer and Chronic Kidney Disease: A Position Statement from the American Society of Onco-Nephrology (ASON)
inferred← citeshttps://doi.org/10.1016/j.kisu.2020.11.002openalex-snapshot
The evolving science of anemia management in chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.kisu.2020.12.003openalex-snapshot
Iron metabolism and management: focus on chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mam.2020.100873openalex-snapshot
Iron deficiency and supplementation in heart failure and chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mpmed.2019.06.014openalex-snapshot
Cardiovascular complications of chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mpmed.2019.06.015openalex-snapshot
Anaemia and chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mpmed.2020.12.007openalex-snapshot
Management and complications of patients on renal replacement therapy on AMU
inferred← citeshttps://doi.org/10.1016/j.mpmed.2022.12.008openalex-snapshot
Cardiovascular complications of chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mpmed.2022.12.009openalex-snapshot
Anaemia and chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.mpmed.2024.12.005openalex-snapshot
Management and complications of patients on renal replacement therapy on AMU
inferred← citeshttps://doi.org/10.1016/j.nefro.2020.07.009openalex-snapshot
Intravenous iron in heart failure and chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.nefro.2020.11.003openalex-snapshot
Ferroterapia en el manejo de la anemia en la enfermedad renal crónica no en diálisis: perspectiva del grupo de anemia de la S.E.N
inferred← citeshttps://doi.org/10.1016/j.nefro.2022.11.009openalex-snapshot
Aspectos no resueltos en el manejo de la anemia renal, un consenso Delphi del Grupo de Anemia de la S.E.N
inferred← citeshttps://doi.org/10.1016/j.nefro.2024.06.006openalex-snapshot
Impact of iron chelation with deferasirox on telomere length and oxidative stress in hemodialysis patients: A randomized study
inferred← citeshttps://doi.org/10.1016/j.nefro.2026.501576openalex-snapshot
Documento de posicionamiento del Grupo de Anemia de la SEN: una lectura crítica y adaptada de las guías de anemia KDIGO 2026 a la realidad española
inferred← citeshttps://doi.org/10.1016/j.nefroe.2020.11.011openalex-snapshot
Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society Anaemia Group
inferred← citeshttps://doi.org/10.1016/j.nefroe.2021.10.007openalex-snapshot
Intravenous iron in heart failure and chronic kidney disease
inferred← citeshttps://doi.org/10.1016/j.nefroe.2023.10.005openalex-snapshot
Unresolved aspects in the management of renal anemia, a Delphi consensus of the Anemia Group of the S.E.N
inferred← citeshttps://doi.org/10.1016/j.nefroe.2025.01.003openalex-snapshot
Impact of iron chelation with deferasirox on telomere length and oxidative stress in hemodialysis patients: A randomized study
inferred← citeshttps://doi.org/10.1016/j.nefroe.2026.501576openalex-snapshot
Position statement of the SEN Anemia Working Group: A critical and contextualized adaptation of the KDIGO 2026 anemia guidelines to the Spanish setting
inferred← citeshttps://doi.org/10.1016/j.nephro.2019.10.002openalex-snapshot
Utilisation du fer en néphrologie : enquête sur les pratiques des néphrologues français
inferred← citeshttps://doi.org/10.1016/j.nephro.2021.12.003openalex-snapshot
Prévalence de la carence martiale dans une population de patients insuffisants rénaux chroniques non dialysés : étude nationale multicentrique observationnelle CARENFER
inferred← citeshttps://doi.org/10.1016/j.nephro.2022.10.003openalex-snapshot
Prise en charge de la carence martiale au cours de la maladie rénale chronique : mise au point et proposition d’un algorithme
inferred← citeshttps://doi.org/10.1016/j.phrs.2020.104747openalex-snapshot
Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1016/j.ptdy.2018.12.024openalex-snapshot
High-dose iron benefits in hemodialysis
inferred← citeshttps://doi.org/10.1016/j.rce.2019.09.004openalex-snapshot
Manejo del déficit de hierro en distintas situaciones clínicas y papel del hierro intravenoso: recomendaciones del Grupo Español de Eritropatología de la SEHH
inferred← citeshttps://doi.org/10.1016/j.rce.2019.11.002openalex-snapshot
¿Es siempre el tratamiento con hierro oral la mejor opción terapéutica?
inferred← citeshttps://doi.org/10.1016/j.rceng.2019.09.010openalex-snapshot
Management of iron deficiency in various clinical conditions and the role of intravenous iron: Recommendations of the Spanish erythropathology group of the Spanish society of hematology and hemotherapy
inferred← citeshttps://doi.org/10.1016/j.rceng.2019.11.002openalex-snapshot
Is oral iron always the best option?
inferred← citeshttps://doi.org/10.1016/j.scib.2023.07.032openalex-snapshot
Hypoxia and panvascular diseases: exploring the role of hypoxia-inducible factors in vascular smooth muscle cells under panvascular pathologies
inferred← citeshttps://doi.org/10.1016/j.slast.2024.100160openalex-snapshot
Application of intelligent nursing system based on big data in maintenance hemodialysis patients
inferred← citeshttps://doi.org/10.1016/j.transci.2021.103139openalex-snapshot
Attitude changes in prescribing intravenous iron supplementation in different settings at a hospital consortium in Italy
inferred← citeshttps://doi.org/10.1016/j.trre.2026.101043openalex-snapshot
Preventing delayed graft function after kidney transplantation: The emerging role of the perioperative period
inferred← citeshttps://doi.org/10.1016/j.xkme.2020.01.006openalex-snapshot
Iron Administration, Infection, and Anemia Management in CKD: Untangling the Effects of Intravenous Iron Therapy on Immunity and Infection Risk
inferred← citeshttps://doi.org/10.1016/j.xkme.2020.06.008openalex-snapshot
Clinical and Economic Outcomes of Erythropoiesis-Stimulating Agent Hyporesponsiveness in the Post-Bundling Era
inferred← citeshttps://doi.org/10.1016/j.xkme.2020.08.002openalex-snapshot
Erythropoiesis-Stimulating Agent Hyporesponsiveness and Adverse Outcomes: Guilty as Charged?
inferred← citeshttps://doi.org/10.1016/j.xkme.2021.01.011openalex-snapshot
Anemia Management in Peritoneal Dialysis: Perspectives From the Asia Pacific Region
inferred← citeshttps://doi.org/10.1016/j.xkme.2023.100681openalex-snapshot
Treatment Options for Anemia in Kidney Transplant Patients: A Review
inferred← citeshttps://doi.org/10.1016/j.xkme.2023.100705openalex-snapshot
Heart Failure With Preserved Ejection Fraction With CKD: A Narrative Review of a Multispecialty Disorder
inferred← citeshttps://doi.org/10.1016/j.xkme.2025.100997openalex-snapshot
Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program
inferred← citeshttps://doi.org/10.1016/s0140-6736(20)32594-0openalex-snapshot
Iron deficiency
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)01988-2openalex-snapshot
Evaluating the results of MyTEMP, a cluster randomised trial of lower temperature haemodialysis: the end of a cool idea?
inferred← citeshttps://doi.org/10.1016/s0140-6736(22)02083-9openalex-snapshot
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
inferred← citeshttps://doi.org/10.1016/s1762-0945(23)43178-6openalex-snapshot
10.1016/s1762-0945(23)43178-6
inferred← citeshttps://doi.org/10.1016/s1769-7255(22)00650-2openalex-snapshot
Innovations thérapeutiques dans la prise en charge de l’anémie de la maladie rénale chronique Therapeutic innovations in the management of chronic kidney disease-associated anemia
inferred← citeshttps://doi.org/10.1016/s2352-3026(19)30264-9openalex-snapshot
Intravenous iron: a framework for changing the management of iron deficiency
inferred← citeshttps://doi.org/10.1038/s41569-023-00903-0openalex-snapshot
FGF23 and klotho at the intersection of kidney and cardiovascular disease
inferred← citeshttps://doi.org/10.1038/s41581-019-0128-5openalex-snapshot
PIVOTAL trial: iron loading improves clinical outcomes
inferred← citeshttps://doi.org/10.1038/s41581-019-0197-5openalex-snapshot
The multifaceted role of iron in renal health and disease
inferred← citeshttps://doi.org/10.1038/s41598-020-72827-5openalex-snapshot
A randomised trial evaluating the effect of intraoperative iron administration
inferred← citeshttps://doi.org/10.1038/s41598-022-05200-3openalex-snapshot
Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study
inferred← citeshttps://doi.org/10.1038/s41598-022-10717-8openalex-snapshot
Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial
inferred← citeshttps://doi.org/10.1038/s41598-022-23262-1openalex-snapshot
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
inferred← citeshttps://doi.org/10.1038/s41598-023-28440-3openalex-snapshot
Maintenance intravenous iron in hemodialysis patients to minimize erythropoietin doses: a double-blinded, randomized controlled trial (the MAINTAIN IRON trial)
inferred← citeshttps://doi.org/10.1053/j.ackd.2019.05.001openalex-snapshot
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients
inferred← citeshttps://doi.org/10.1053/j.ackd.2019.05.002openalex-snapshot
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease
inferred← citeshttps://doi.org/10.1053/j.ackd.2019.05.006openalex-snapshot
Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual?
inferred← citeshttps://doi.org/10.1053/j.ackd.2022.03.005openalex-snapshot
Anemia Management in the Cancer Patient With CKD and End-Stage Kidney Disease
inferred← citeshttps://doi.org/10.1053/j.ajkd.2019.01.016openalex-snapshot
A Pivot Towards Moderating Intravenous Iron Therapy in Hemodialysis
inferred← citeshttps://doi.org/10.1053/j.ajkd.2022.11.007openalex-snapshot
Associations of Iron Sucrose and Intradialytic Blood Pressure
inferred← citeshttps://doi.org/10.1053/j.ajkd.2023.01.439openalex-snapshot
Iron Sucrose and Blood Pressure Patterns During Hemodialysis
inferred← citeshttps://doi.org/10.1053/j.ajkd.2024.09.006openalex-snapshot
Vadadustat Three Times Weekly in Patients With Anemia Due to Dialysis-Dependent CKD
inferred← citeshttps://doi.org/10.1053/j.ajkd.2026.03.036openalex-snapshot
KDOQI US Commentary on the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in CKD
inferred← citeshttps://doi.org/10.1055/a-0810-8596openalex-snapshot
Intravenöse Eisensubstitution bei chronischer Erkrankung – bei wem, wann und wie?
inferred← citeshttps://doi.org/10.1055/a-0886-1263openalex-snapshot
Medikamentöse Therapie des kardiorenalen Syndroms
inferred← citeshttps://doi.org/10.1055/a-0887-0792openalex-snapshot
Medikamentöse Therapie der Herzinsuffizienz mit reduzierter Ejektionsfraktion bei chronischer Nierenerkrankung
inferred← citeshttps://doi.org/10.1055/a-0991-9623openalex-snapshot
Eisentherapie bei Dialysepatienten
inferred← citeshttps://doi.org/10.1055/a-1133-7849openalex-snapshot
Anämie und Eisenmangel – Behandlungsoptionen bei chronischer Nierenerkrankung und chronischer Herzinsuffizienz
inferred← citeshttps://doi.org/10.1055/a-1240-7579openalex-snapshot
Eisenmangel bei chronischer Nierenerkrankung
inferred← citeshttps://doi.org/10.1055/a-1402-8805openalex-snapshot
Therapie der renalen Anämie
inferred← citeshttps://doi.org/10.1055/a-1990-9410openalex-snapshot
Eisentherapie bei chronischer Nierenkrankheit: Viel hilft viel oder ist weniger mehr?
inferred← citeshttps://doi.org/10.1055/a-2192-4493openalex-snapshot
Epos EPO
inferred← citeshttps://doi.org/10.1055/a-2193-2993openalex-snapshot
Eisen bei der Behandlung der renalen Anämie
inferred← citeshttps://doi.org/10.1055/a-2511-0543openalex-snapshot
Eisen in der Therapie der Anämie bei Nierenkrankheit
inferred← citeshttps://doi.org/10.1055/a-2529-8299openalex-snapshot
Lebensqualität bei Dialysepatienten unter Anämietherapie
inferred← citeshttps://doi.org/10.1055/a-2818-5323openalex-snapshot
Intravenöse Eisenverwendung bei chronischer Nierenerkrankung
inferred← citeshttps://doi.org/10.1056/nejmc1902945openalex-snapshot
Intravenous Iron and Maintenance Hemodialysis
inferred← citeshttps://doi.org/10.1080/00325481.2026.2692142openalex-snapshot
The prevalence of functional iron deficiency and its impact on mortality in patients receiving hemodialysis
inferred← citeshttps://doi.org/10.1080/03007995.2022.2092373openalex-snapshot
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety
inferred← citeshttps://doi.org/10.1080/07853890.2020.1867323openalex-snapshot
Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice
inferred← citeshttps://doi.org/10.1080/0886022x.2020.1811121openalex-snapshot
Effect of hypoxia-inducible factor-prolyl hydroxylase inhibitors on anemia in patients with CKD: a meta-analysis of randomized controlled trials including 2804 patients
inferred← citeshttps://doi.org/10.1080/0886022x.2023.2230300openalex-snapshot
Bone marrow macrophage iron content and sideroblast count in iron- and ESA-naïve patients with CKD-related anemia
inferred← citeshttps://doi.org/10.1080/0886022x.2024.2308701openalex-snapshot
Influencing factors of clinical efficacy of roxadustat among hemodialysis patients
inferred← citeshttps://doi.org/10.1080/0886022x.2024.2353339openalex-snapshot
γ-Gammaglutamyl transferase predicts all-cause mortality within three-year intervals in patients undergoing peritoneal dialysis
inferred← citeshttps://doi.org/10.1080/0886022x.2026.2644786openalex-snapshot
Effect of IV ferric carboxymaltose treatment on platelet counts and serum transferrin levels in CKD patients not on dialysis with iron deficiency: potential implications for thrombogenicity
inferred← citeshttps://doi.org/10.1080/0886022x.2026.2694788openalex-snapshot
Proactive iron supplementation alone in patients on chronic hemodialysis is not sufficient
inferred← citeshttps://doi.org/10.1080/13543784.2020.1777276openalex-snapshot
Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease?
inferred← citeshttps://doi.org/10.1080/13696998.2019.1588738openalex-snapshot
Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review
inferred← citeshttps://doi.org/10.1080/14656566.2022.2150545openalex-snapshot
Ferumoxytol: an emerging therapeutic for iron deficiency anemia
inferred← citeshttps://doi.org/10.1080/14656566.2024.2374039openalex-snapshot
Can we effectively manage chronic kidney disease with a precision-based pharmacotherapy plan? Where are we?
showing the first 200 of 500
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.